Legend Biotech (LEGN) Times Interest Earned (2019 - 2025)
Legend Biotech (LEGN) posted Times Interest Earned of $3.58 for Q4 2025, down 53.54% on a QoQ basis from $7.71 in Q3 2025, and down 76.51% year-over-year from $15.25 in Q4 2024.
Legend Biotech (LEGN) has 7 years of Times Interest Earned data on file, last reported at $3.58 in Q4 2025.
- In Q4 2025, Times Interest Earned fell 76.51% year-over-year to $3.58; the TTM figure through Dec 2025 stood at -$26.25 (up 21.33% YoY), while the FY2025 annual figure was $6.38, down 55.48% from the prior year.
- Times Interest Earned eased to $3.58 in Q4 2025, from $7.71 in the prior quarter.
- Across five years, Times Interest Earned topped out at $37.02 in Q1 2024 and bottomed at -$13.7 million in Q4 2023.
- A 5-year average of -$700455.2 and a median of -$42.71 in 2022 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2023 — Times Interest Earned plunged 60752390.97% — and 2024, when it jumped 136.48%.
- Year by year, Times Interest Earned stood at -$149.22 in 2021, then surged by 84.94% to -$22.47 in 2022, then plunged by 60752390.97% to -$13.7 million in 2023, then surged by 100.0% to $15.25 in 2024, then sank by 76.51% to $3.58 in 2025.
- The last three Times Interest Earned figures came in at $3.58 (Q4 2025), $7.71 (Q3 2025), and -$64.71 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.88 |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -36.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.58 |
| Sep 30, 2025 | 7.71 |
| Jun 30, 2025 | -64.71 |
| Mar 31, 2025 | 56.80 |
| Dec 31, 2024 | 15.25 |
| Sep 30, 2024 | 12.78 |
| Jun 30, 2024 | -55.51 |
| Mar 31, 2024 | -37.02 |
| Dec 31, 2023 | -13.65 Mn |
| Sep 30, 2023 | -35.04 |
| Jun 30, 2023 | -33.84 |
| Mar 31, 2023 | -24.54 |
| Dec 31, 2022 | -22.47 |
| Sep 30, 2022 | -41.95 |
| Jun 30, 2022 | -43.46 |
| Mar 31, 2022 | -117.76 |
| Dec 31, 2021 | -149.22 |
| Sep 30, 2021 | -391.68 |
| Jun 30, 2021 | -1,849.17 |
| Mar 31, 2021 | -352,716.79 |
| Dec 31, 2020 | -2,317.65 |
| Sep 30, 2020 | -801.71 |
| Jun 30, 2020 | -683.16 |
| Mar 31, 2020 | -14.14 |
| Dec 31, 2019 | -883.58 |
| Sep 30, 2019 | -696.62 |
| Jun 30, 2019 | -2,068.63 |